2025-10-29 • Microdosing Institute

Cognitive and Subjective Effects of Psilocybin Microdosing: Results from Two Double-Blind Placebo-Controlled Longitudinal Trials

Microdosing Research

These two randomised, double-blind, placebo-controlled trials (n=141) conducted in semi-naturalistic settings found that microdosing psilocybin truffles did not significantly affect cognitive control, memory, social cognition, subjective well-being, attention, mood, or self-reported cognitive flexibility compared to placebo. Initial effects in some domains did not remain significant after correcting for multiple comparisons.

External link. We are not responsible for the content.

Read more ↗

More From Microdosing Institute

2025-11-24 • Microdosing Institute

Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial

This qualitative study (n=40) of healthy males following a double-blind placebo-controlled trial of LSD microdosing (...

Microdosing Research
2025-11-10 • Microdosing Institute

LSD microdosing in major depressive disorder: results from an open-label trial

This open-label Phase IIa trial (n=19, 15 male) found that an 8-week regimen of microdosed LSD (8μg initially, then 6...

Microdosing Research
2025-09-19 • Microdosing Institute

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers

This randomised, placebo-controlled study (n=48) examining LSD microdosing (15 μg) for analgesia in healthy participa...

Microdosing Research

Latest News

2026-02-28 • Chemical Collective

Comment perfectionner la préparation de son trip ?

La préparation d’un voyage est un processus à la fois intérieur et extérieur – qui consiste à aligner l’intention, l’...

2026-02-27 • Lucid News

Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day

Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of...

Microdosing Research
2026-02-27 • The Microdose (Berkeley)

The FDA is changing the drug approval process; In a Senate hearing, Surgeon General nominee Casey Means was asked about psychedelics use

Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuro...

2026-02-27 • Psychedelic Alpha

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

In this conversation with Psychedelic Alpha’s Josh Hardman, Dr. Terence Ching discusses his journey into the field an...

2026-02-27 • Tripsitter (Substack)

Can Psychedelics Break the Consumption Cycle?

Consumer culture doesn’t just shape what we buy — it shapes what we want. Here’s why that’s harder to escape than you...

2026-02-27 • The Psychedelic Blog (Substack)

Psychedelics Can Just Be for Fun

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.